Pursuant to Regulation 32 of the SEBI(LODR) Regulation, 2015 Read with SEBI circular dated 24th December, 2019 regarding the submission of the statement of deviation or variation from the proceeds of public issue/rights issue/preferential issue, qualified institutional placement etc. we hereby confirm that the company has not raised any further funds by means of Public Issue, rights issue or preferential issue etc. hence the statement of deviation and variation is not applicable to the company.
Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations, 2015
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Earlier from Vivanza Biosciences
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Vivanza Biosciences Ltd. Press Release Aug 07 2026
- Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited ('The Company')
- Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026
- Vivanza Biosciences Ltd. Press Release Jul 31 2026
Later from Vivanza Biosciences
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vivanza Biosciences Ltd. Press Release Aug 12 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026
- Vivanza Biosciences Ltd. Press Release Aug 17 2026
- Notice Of The 44Th Annual General Meeting (''''AGM'''') And Annual Report Of The Company For The Financial Year 2025-26
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences